Identification of the histidyl residue obligatory for the catalytic activity of the human H+/peptide cotransporters PEPT1 and PEPT2
- PMID: 9003198
- DOI: 10.1021/bi962058p
Identification of the histidyl residue obligatory for the catalytic activity of the human H+/peptide cotransporters PEPT1 and PEPT2
Abstract
Histidyl residues are known to be essential for the catalytic function of the H(+)-coupled peptide transporters expressed in the intestine and the kidney, most likely participating in the binding and translocation of H+. Three histidyl residues are conserved among the intestinal and renal peptide transporters (PEPT1 and PEPT2, respectively) from different animal species. In hPEPT1, these residues are His-57, His-121, and His-260. The corresponding residues in hPEPT2 are His-87, His-142, and His-278. We have individually mutated each of these histidyl residues in hPEPT1 and in hPEPT2 and compared the catalytic function of the mutants with that of their respective wild type transporters by expressing the transporters in Xenopus laevis oocytes and also in HeLa cells. His-57 in hPEPT1 and His-87 in hPEPT2 were found to be absolutely essential for catalytic activity because the corresponding mutants had no detectable peptide transport activity. His-121 in hPEPT1 is not essential since mutation of this residue did not impair transport function. His-142 in hPEPT2 was found to play a significant role in the maintenance of transport function but was not found to be obligatory because the mutant had appreciable transport activity. The obligatory histidyl residue (His-57 in hPEPT1 and His-87 in hPEPT2) is located in an almost identical topological position in both transporters, near the extracellular surface of the second putative transmembrane domain. The second conserved histidyl residue is located in the fourth putative transmembrane domain in hPEPT1 as well as in hPEPT2. The third conserved histidyl residue is present in the cytoplasmic loop between the transmembrane domains 6 and 7 and is unlikely to play any significant role in the binding and translocation of H+ and this was supported by the findings that mutation of this histidyl residue in hPEPT1 did not interfere with transport function. The loss of transport function of hPEPT1 and hPEPT2, when His-57 in hPEPT1 and His-87 in hPEPT2 were mutated, was not due to alterations in protein expression because the expression levels of these mutants were similar to those of the respective wild type transporters in HeLa cells as assessed by immunoblot analysis. Confocal analysis of immunofluorescence in X. laevis oocytes expressing the wild type and the three histidine mutants of hPEPT1 showed that the transporter protein is expressed exclusively in the plasma membrane and that the level of expression is comparable among the wild type and the three mutants. These site-directed mutagenesis studies clearly show that His-57 in hPEPT1 and His-87 in hPEPT2 are the most critical histidyl residues necessary for the catalytic function of these transporters.
Similar articles
-
Functional roles of histidine and tyrosine residues in the H(+)-peptide transporter PepT1.Biochem Biophys Res Commun. 2000 Jun 16;272(3):726-30. doi: 10.1006/bbrc.2000.2851. Biochem Biophys Res Commun. 2000. PMID: 10860823
-
The bioactive dipeptide anserine is transported by human proton-coupled peptide transporters.FEBS J. 2010 Feb;277(3):790-5. doi: 10.1111/j.1742-4658.2009.07528.x. Epub 2010 Jan 8. FEBS J. 2010. PMID: 20067523
-
Membrane topology of the human dipeptide transporter, hPEPT1, determined by epitope insertions.Biochemistry. 1998 Oct 27;37(43):15214-21. doi: 10.1021/bi981128k. Biochemistry. 1998. PMID: 9790685
-
[Molecular characteristics and tissue distribution of peptide transporters].Sheng Li Ke Xue Jin Zhan. 2003 Jul;34(3):222-6. Sheng Li Ke Xue Jin Zhan. 2003. PMID: 14628467 Review. Chinese.
-
Di/tri-peptide transporters as drug delivery targets: regulation of transport under physiological and patho-physiological conditions.Curr Drug Targets. 2003 Jul;4(5):373-88. doi: 10.2174/1389450033491028. Curr Drug Targets. 2003. PMID: 12816347 Review.
Cited by
-
Functional properties of the Arabidopsis peptide transporters AtPTR1 and AtPTR5.J Biol Chem. 2010 Dec 17;285(51):39710-7. doi: 10.1074/jbc.M110.141457. Epub 2010 Oct 11. J Biol Chem. 2010. PMID: 20937801 Free PMC article.
-
Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution.Naunyn Schmiedebergs Arch Pharmacol. 2004 Jan;369(1):69-77. doi: 10.1007/s00210-003-0813-5. Epub 2003 Nov 4. Naunyn Schmiedebergs Arch Pharmacol. 2004. PMID: 14598019 Review.
-
Molecular Insights to the Structure-Interaction Relationships of Human Proton-Coupled Oligopeptide Transporters (PepTs).Pharmaceutics. 2023 Oct 23;15(10):2517. doi: 10.3390/pharmaceutics15102517. Pharmaceutics. 2023. PMID: 37896276 Free PMC article. Review.
-
Residues R282 and D341 act as electrostatic gates in the proton-dependent oligopeptide transporter PepT1.J Physiol. 2011 Feb 1;589(Pt 3):495-510. doi: 10.1113/jphysiol.2010.200469. Epub 2010 Nov 29. J Physiol. 2011. PMID: 21115649 Free PMC article.
-
Biophysical evidence for His57 as a proton-binding site in the mammalian intestinal transporter hPepT1.Pharm Res. 2003 Dec;20(12):1911-6. doi: 10.1023/b:pham.0000008036.05892.e9. Pharm Res. 2003. PMID: 14725353
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
